PresentaciÃ³n Su elaboraciÃ³n en formato electrÃ³nico, iniciada en ...

More documents

Recommendations

Info

DRUG andALCOHOLDEPENDENCEVolume 72, Issue 2, 24 November 2003CONTENTSReview articleInjury risk associated with cannabis and cocaine useS. Macdonald, K. Anglin-Bodrug, R.E. Mann, P. Erickson, A. Hathaway, M. Chipman, M. Rylett…....99FulI length reportsSubstance use in a sample of Turkish medical studentsY. Akvardar, Y. Demiral, G. Ergór, A. Ergór, M. Bilici, Ó.A. Ózer. ........................... . 117Predictors of attendance in a randomized clinical trial of nicotine replacement therapy withbehavioral counselingF. Patterson, C. Jepson, V. Kaufmann, M. Rukstalis, J. Audrain-McGovern, S. Kucharski, C. Lerman.………………………………………………………………………………………………………………....123Reduced cardiovascular effects of methamphetamine following treatment with selegilineC.W. Schindler, J.P. Gilman, Z. Graczyk, G. Wang, W.L. Gee …......................... 133Escalating morphine exposures followed by withdrawal in feline immunodeficiency virus-infectedcats: a model for HIV infection in chronic opiate abusersM.C. Barr, S. Huitron-Resendiz, M. Sanchez-Alavez, S J. Henriksen, T.R. Phillips. . … … ... 141Finding order in the DSM-IV nicotine dependence syndrome: a Rasch analysisD.R. Strong, C.W. Kahler, S.E. Ramsey, R.A. Brown ................................... 151An independent assessment of MEDWatch reporting for abuse/dependence and withdrawalfrom Ultram (tramadol hydrochloride)G.E. Woody, E.C. Senay, A. Geller, E.H. Adams, J.A. Inciardi, S. Schnoll,A. Muñoz, T.J. Cicero. . . . ...........…………………………………................ . 163The pharmacology of cocaethylene in humans following cocaine and ethanol administrationD.S. Harris, E. Thomas Everhart, J. Mendelson, R.T. Jones ............................. 169Item functioning of the alcohol dependence scale in a high-risk sampleC.W. Kahler, D.R. Strong, G.L. Stuart, T.M. Moore, S.E. Ramsey ........................ 183Short CommunicationsThe effect of drugs of abuse on NMDAR1 receptor expression in the rat limbic systemJ. Turchan, M. Maj, B.Przewlocka....................................................................... 193Risky sexual behavior in relation to marijuana and alcohol use among African-American,male adolescent detainees and their female partnersJ.B. Kingree, H. Betz .............................................................. 197Calendar of forthcoming meetings ….................................................. 205
DRUG andALCOHOLDEPENDENCEVolume 72, Issue 3, 11 December 2003CONTENTSPublisher's note..................................................................................... 207Full length reportsTelephone versus in-person interviews for alcohol use: results of the 2000 National Alcohol SurveyL.T. Midanik, T.K. Greenfield .......................................................... 209Effects of identification and usefulness of the Lie Scale of the Drug Use ScreeningInventory (DUSI-R) in the assessment of adolescent drug useH.R.F. Dalla-Déa, D. De Micheli, M.L.O.S. Forraigoni ...................................... 215Reduced cortical gray matter density in human MDMA (Ecstasy) users: avoxel-based morphometry studyR.L. Cowan, I.K. Lyoo, S.M. Sung, K.H. Ahn, M.J. Kim, J. Hwang, E. Haga, R.L.P. Vimal,S.E. Lukas, P.F. Renshaw ............……………………………………………….... 225Examining mechanisms of action in 12-Step community outpatient treatmentJ. Morgenstern, D.A. Bux Jr., E. Labouvie, T. Morgan, K.A. Blanchard, F. Muench ............. 237Smoking status and substance abuse severity in a residential treatment sampleJ. Krejci, M.L. Steinberg, D. Ziedonis....................................……. ......... 249Gender comparisons of drug abuse treatment outcomes and predictorsY.-I. Hser, D. Huang, C. Teruya, M. Douglas Anglin ..............……..............….... 255Is oral fluid analysis as accurate as urinalysis in detecting drug use in a treatment setting?G.A. Bennett, E. Davies, P. Thomas .................................................... 265The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine,alone and in combination with alcohol, on simulated drivingM.G. Lenné, P. Dietze, G.R. Rumbold, J.R. Redman, T.J. Triggs ........................... 271Brief measures of sensation seeking for screening and large-scale surveysM.T. Stephenson, R.H. Hoyle, P. Palmgreen, M.D. Slater .................................. 279Comprehensive deficits in performance of an attentional task produced by coadministeringalcohol and nicotine to ratsL. Bizarro, S. Patel, I.P. Stolerman ..................................................... 287Opiate maintenance with buprenorphine in ambulatory care: a 24-weekfollow-up study of new usersM. Lapeyre-Mestre, M.-E. Llau, M. Gony, A.-M. Navel, J. Bez, M. Grau, J.-L. Montastruc.................................... 297Calendar of forthcoming meetings ...................................................... 305Volume contents..................................................................... 307
Page 1 and 2:
PresentaciónSu elaboración en for
Page 6 and 7:
• FUENTES GONZALEZ G. (2003). PRO
Page 8 and 9:
• SAUNDERS J., YOUNG R. (2002). A
Page 10 and 11:
• LUNA MALDONADO A. (2003). APROX
Page 12 and 13:
• HANAK C., TECCO J., VERBANCK P.
Page 14 and 15:
• MARTÍNEZ GONZÁLEZ J.M. (2003)
Page 16 and 17:
• COMAS ARNAU D.; coord. AGUINAGA
Page 18 and 19:
• RANZETTA L., FITZPTRICK J., SEL
Page 20 and 21:
• CASTELLO NICAS N. (2003). EXENC
Page 22 and 23:
• LUNA JIMENEZ DE PARGA P., GALLA
Page 24 and 25:
• VALLS PRIETO J. (2003). LEGISLA
Page 26:
• KUHN C., SWARTZWELDER S., WILSO
Page 29 and 30:
• NATIONAL INSTITUTE ON DRUG ABUS
Page 31 and 32: • BRAVO D. (2001). UNIDAD MOVIL D
Page 33 and 34: • GOLTZMAN P., CYMERMAN P., ROSSI
Page 35 and 36: • RADULICH G.C., VIVAS L.E., BRUN
Page 37 and 38: • VITORIA ISUSI A.; coord., ALVAR
Page 39 and 40: • JIMENEZ M., MONASOR R.,RUBIO VA
Page 41 and 42: • CALAFAT FAR A., JUAN M. (2003).
Page 43 and 44: • SASOIA. EDUCACION PARA LA SALUD
Page 45 and 46: • LADERO QUESADA J.M., MARTIN DEL
Page 47 and 48: • LADERO QUESADA J.M., MARTIN DEL
Page 49 and 50: • JOHANSSON B.A. (2003). PHARMACO
Page 51 and 52: • ESPAÑA. MINISTERIO DE SANIDAD
Page 53 and 54: • ANDALUCIA (COMUNIDAD AUTONOMA).
Page 55 and 56: • JENSEN E.L. (2003). SANCIONES N
Page 57 and 58: • NACIONES UNIDAS. PROGRAMA MUNDI
Page 59 and 60: • ESPAÑA. PLAN NACIONAL SOBRE DR
Page 61 and 62: BOE 16/12/2003MINISTERIO DEL INTERI
Page 63 and 64: BOE 19/12/2003COMUNIDAD AUTÓNOMA D
Page 65 and 66: Addiction .........................
Page 67 and 68: AddictionVOLUME 98 • SUPPLEMENT 2
Page 69 and 70: ………….ADDICTIVE BEHAVIORSAN
Page 71 and 72: ADDICTIVE BEHAVIORSAN INTERNATIONAL
Page 73 and 74: ADDICTIVE BEHAVIORSAN INTERNATIONAL
Page 75 and 76: adicciones Monografía Drogas recre
Page 77 and 78: THE AMERICAN JOURNAL OF DRUG AND AL
Page 79 and 80: CDD DDZCentro de Documentaciónde d
Page 81: CDD DDZCentro de Documentaciónde d
Page 85 and 86: DRUG andALCOHOLDEPENDENCEVolume 73,
Page 87 and 88: IDEA prevenciónnº 27 julio/diciem
Page 89 and 90: Volume 22 Number 3 2003CONTENTSEDIT
Page 91 and 92: Buprenorphine for Opiate Dependence
Page 93 and 94: Circuit Parties and Patterns of Dru
Page 95 and 96: 963 Towards an HIV Role Theory: Dru
Page 97 and 98: Drug Use Among Texas Alternative Sc
Page 99 and 100: Contents (continued)GOLDSTEIN, A.L.
Page 101 and 102: Journal of Substance Abuse Treatmen
Page 103 and 104: Journal of Substance Abuse Treatmen
Page 105 and 106: PSYCHOLOGY OFADDICTIVE BEHAVIORSVol
Page 107 and 108: PUBLIC HEALTH ReportVOLUME 118 NUMB
Page 113 and 114: REVISTA DE ESTUDIOS DE JUVENTUDNº
Page 115 and 116: RTS - REVISTA DE TREBALL SOCIALNúm
Page 117 and 118: Contents ContinuedRESEARCH NOTESCli
Page 119 and 120: TOBACCO CONTROLDecember 2003Vol. 12
Page 121: trastornosadictivosVolumen 6 • N
show all

PresentaciÃ³n Su elaboraciÃ³n en formato electrÃ³nico, iniciada en ...

Create successful ePaper yourself

Delete template?

Save as template?